GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » 3-Year RORE %

Universal Biosensors (ASX:UBI) 3-Year RORE % : -16.67% (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Universal Biosensors's 3-Year RORE % for the quarter that ended in Dec. 2023 was -16.67%.

The industry rank for Universal Biosensors's 3-Year RORE % or its related term are showing as below:

ASX:UBI's 3-Year RORE % is ranked worse than
64.03% of 809 companies
in the Medical Devices & Instruments industry
Industry Median: -4.33 vs ASX:UBI: -16.67

Universal Biosensors 3-Year RORE % Historical Data

The historical data trend for Universal Biosensors's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors 3-Year RORE % Chart

Universal Biosensors Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.02 -180.99 24.14 40.00 -16.67

Universal Biosensors Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.00 34.62 30.43 21.74 -16.67

Competitive Comparison of Universal Biosensors's 3-Year RORE %

For the Medical Devices subindustry, Universal Biosensors's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Biosensors's 3-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's 3-Year RORE % falls into.



Universal Biosensors 3-Year RORE % Calculation

Universal Biosensors's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.03--0.07 )/( -0.24-0 )
=0.04/-0.24
=-16.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.


Universal Biosensors  (ASX:UBI) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Universal Biosensors 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Biosensors (ASX:UBI) Business Description

Traded in Other Exchanges
N/A
Address
1 Corporate Avenue, Rowville, VIC, AUS, 3178
Universal Biosensors Inc is a developer of biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in its hand-held portable analysers for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture, enabling high speed, ease of use, reliability, accuracy at low cost.

Universal Biosensors (ASX:UBI) Headlines

No Headlines